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Abstract 
Acute pancreatitis is an inflammatory disease with the clinical manifestation of acute abdominal pain. 
Several factors are involved in the pathogenesis of acute pancreatitis. The exact mechanism(s) by 
which diverse etiological factors induce an attack are still unclear. However, one of the proposed 
mechanisms for induction of acute pancreatitis is auto-digestion of pancreatic tissues by unwanted 
activation of pancreatic digestive enzymes. The main objective of this review is to describe the 
pathogenesis mechanism of acute pancreatitis that are related to various inflammatory and pro-
inflammatory mediators. 
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Acute pancreatitis is an inflammatory disease 
characterized by varying degrees of endogenous 
pancreatic injury ranging from a mild 
oedematous and interstitial process to one which 
is associated with extensive pancreatic and 
peripancreatic necrosis. Complications of acute 
pancreatitis include the development of 
pancreatic pseudocysts, pancreatic ascites, and 
vascular changes such as splenic vein 
thrombosis and development of arterial false 
aneurysms in the area of the pancreas [1]. The 
most severe form of acute pancreatitis is severe 
haemorrhagic and necrotizing pancreatitis, which 
has been reported to result in mortality rates 
ranging from 30 to 50 % through liver and lung 
injury [2]. In particular, liver injury is a clinical 
prognostic indicator and is incorporated into the 
various scoring systems used to predict the 
severity of acute pancreatitis [2,3]. 
 
There are several factors influencing the 
pathogenesis of acute pancreatitis like premature 
activation of trypsinogen, chemokine production, 
and pro-inflammatory cytokine production and 
involvement of cytokine-inducible DNA-binding 
proteins like signal transducers and activators of 
transcription (STAT) proteins, latent transcription 
factors [4]. The synthesis and release of 
cytokines upon inflammatory action mainly 
medicated by oxidative stress mechanisms like 
mitogen activated protein kinases (MAPKs) and 
nuclear factor-κ B (NF-κB) [4].  
 
Free oxygen radicals and pro-inflammatory 
cytokines which are released by neutrophils and 
macrophages during acute pancreatitis, 
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exacerbate the inflammatory response by 
causing an increase in local and systemic 
capillary permeability and by promoting leukocyte 
adhesion and extravasation [3]. The cellular 
mechanism of pro-inflammatory cytokines is 
regulated by nuclear factor-κB (NF-κB) and 
activator protein-1 (AP-1). NF-κB and AP-1 are 
two transcriptional complexes required for the 
early response gene expression of inflammatory 
molecules [3]. It has been reported that 
interleukins IL-1b, IL-6, IL-8, and TNF-α levels 
are significantly increased in both sera and 
tissues of patients with acute pancreatitis [3]. The 
main objective of this review is to collect the 
information about the role of pro-inflammatory 
cytokines in the development of acute 
pancreatitis. 
 
Pathophysiology of acute pancreatitis  
 
Premature activation of digestive enzymes in 
acinar cells during acute pancreatitis results in 
auto-digestion of the pancreas. Trypsinogen, a 
serine protease, is now thought to be the first 
enzyme to be activated; subsequently other 
digestive enzymes (chymotrypsinogen and 
proelastase) are cleaved and activated [5-8]. The 
pancreas has a variety of self-protective 
mechanisms to prevent intracellular zymogen 
activation and subsequent auto-digestion. 
However in acute pancreatitis, these protective 
mechanisms are no longer effective or are 
overwhelmed [5-8]. As a result, the activated 
pancreatic enzymes destroy the pancreatic cell 
membranes and subsequently the entire 
pancreatic tissue, causing pancreatic oedema, 
vascular damage, haemorrhage, and necrosis. 
Strong local inflammatory response activates 
leukocytes and endothelial cells among others. 
Secreted bioactive molecules from infiltrating 
leukocytes contribute to local damage and 
subsequently to the systemic inflammatory 
response, which may result in multiple organ 
dysfunction and ultimately death [9]. A number of 
inflammatory mediators have been implicated in 
the recruitment of leukocytes into the pancreas 
[9]. Inflammatory mediators such as substance P 
and chemokines along with cytokines, 
interleukins, intercellular adhesion molecules and 
platelet activating factor have been shown to play 
significant roles in the pathogenesis of acute 
pancreatitis [9-11].  
 
Role of substance P in the pathogenesis of 
acute pancreatitis 
 
Substance P is an 11-amino acid neuropeptide 
that was originally isolated and purified by Chang 
and Leeman from bovine pituitary glands [12]. It 
is a member of the tachykinin family and has 
been shown to induce rapid smooth muscle 
contraction in guinea pig ileum and rat 
duodenum [12].  
 
Studies have indicated that substance P by 
acting through neurokinin 1 receptor (NK1R) 
stimulates pancreatic acinar cells to release 
chemokines MCP-1, MIP-1a, MIP-2 and 
RANTES by PLC- dependent mechanisms 
(Figure 1). The released chemokines acting via 
chemokine receptors facilitate the release of 
cytokines (IL-1, IL-8 and TNF-α) as shown in 
Figure 2, which play an important role in the 
pathogenesis of acute pancreatitis [11,13-15]. 
Both genetic deletion of NK1R and blockade of 
NK1R with its selective antagonist CP96345, 
protected mice against acute pancreatitis and 
associated lung injury [11,16]. Substance P has 
also been shown to play an important role in the 
pathogenesis of asthma, inflammatory bowel 
disease and arthritis [17,18]. Substance P levels 
in the pancreas and NK1R expression on 
pancreatic acinar cells are increased during 
secretagogue-induced experimental pancreatitis 
[11,14,15,19]. It has been suggested that the 
neuropeptide substance P plays an important 
role in the evolution of pancreatic inflammatory 
diseases such as acute pancreatitis [11]. These 
observations indicate that substance P, acting 
through NK1R, plays an important pro-
inflammatory role in regulating the severity of 
acute pancreatitis. Substance P also induces an 
increase in [Ca2+]i which results in the 
phosphorylation of PKCα/βII, ERK and JNK; 
leading to the activation of NF-κB p65, AP-1, c-
Jun and ultimately to chemokine production [20]. 
However, the exact mechanism(s) by which 
substance P contributes to the pro-inflammatory 
signalling in acute pancreatitis is not completely 
understood [20]. 
 
Role of chemokines in the pathogenesis of 
acute pancreatitis 
 
Chemokines are a family of small (8-10 kDa) 
inducible cytokines with activating and 
chemotactic effects on leukocyte subsets. These 
proteins are defined by four invariant cysteine 
residues and are classified into four sub-families 
(two major and two minor) based on the relative 
position of the first two cysteine residues: CXC 
(α-subfamily), CC (β-subfamily), C (γ-subfamily) 
and CX3C (δ-subfamily) chemokines (C stands 
for cysteine and X stands for other amino acids) 
[21].  
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                    Figure 1: Induction of chemokines by substance P in the pancreatic acinar cells 
 
The two major subfamilies CC and CXC 
chemokines have been extensively investigated 
in various disease conditions including acute 
pancreatitis.   
 
Chemokines act as regulators of immune, 
inflammatory and hematopoietic processes. They 
play a major role in leukocyte trafficking, 
recruitment and recirculation. The CC chemokine 
family members include monocyte 
chemoattractant protein- 1 (MCP-1), MCP-2, 
macrophage inflammatory protein; MIP-1a, MIP-
1b, RANTES, eotaxin and thymus- and 
activation-regulated chemokine (TARC). The CC 
chemokines serves as chemoattractant for 
monocytes/macrophages, activated T-cells, B-
cells, eosinophils, basophils and dendritic cells. 
[22,23].   
 
A study of chemokine gene expression in rat 
pancreatic acinar cells showed an up-regulated 
rat CXC chemokine mob-1 and CC chemokine 
MCP-1 mRNA expression within 1 h of cerulein- 
induced acute pancreatitis in vivo. The mob-1 
mRNA was also induced by either retrograde 
injection of bile salts or cerulein in acinar cells in 
vitro [24,25]. An in vitro study on cholecystokinin 
(CCK)- and ethanol-treated rat pancreatic acinar 
cells demonstrated that rat pancreatic acinar 
cells secreted MCP-1 and RANTES in response 
to CCK and ethanol stimulation, suggesting a 
role for these two chemokines in the 
pathogenesis of acute pancreatitis [26]. It has 
also been shown that cerulein hyper-stimulation 
induced synthesis of MCP-1 but not CINC in rat 
pancreatic acinar cells [9]. This MCP-1 synthesis 
is mediated through a calcium-dependent 
mechanism involving NFκB activation.   
 
The role of MCP-1 as well as two other CC 
chemokines MIP-1α and MIP-1β has been 
extensively evaluated in human acute 
pancreatitis. It was found that complicated acute 
pancreatitis is associated with significantly 
elevated levels of local and systemic 
concentrations of MCP-1 and MIP-1α [27]. A 
close correlation between the severity of remote 
organ failure and the degree of MCP-1 elevation 
suggests that MCP-1 might play a pivotal role in 
the pathological mechanism of complicated 
human acute pancreatitis [27]. MCP-1 is believed 
to contribute to the progression of chronic 
pancreatitis which results from repetitive 
pancreatic injury with sustained production of 
various pro-inflammatory cytokines and 
chemokines through monocyte/macrophage 
recruitment [28]. Moreover, it has been reported 
that blockade of MCP-1 could reduce the 
development of pancreatic fibrosis in chronic 
pancreatitis [29]. 
 
Role of nuclear factor κB (NFκB) in the 
pathogenesis of acute pancreatitis 
 
NFκB activation is a key mediator of the 
inflammatory response in acute pancreatitis [30-
33]. It is an ubiquitous transcription factor which 
is implicated in the regulation of many genes that 
code for mediators of the immune and acute 
phase of inflammatory responses [34].  In a 
classical pathway, NFκB is sequestered in the 
cytoplasm of most resting cells through its 
association with an inhibitory protein called IκB. 
During stimulation by IL-1 or TNF-α, a whole 
cascade of adaptor proteins and protein kinases 
are activated, leading to the phosphorylation of 
IκB by the IκB kinases α and β (IKK α/β) [35].  
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Figure 2: Downhill mechanism of cytokines secretion, as a result of chemokine receptor activation. CAS: Crk-
associated substrate; ERK- Extracellular signal-regulated kinases; PTK- Protein tyrosine kinases; CaM kinase, 
Ca 2+/calmodulin-dependent kinases 
 
This depends on the regulatory protein NEMO/ 
IKK γ (NFκB essential modifier) associated with 
the complex containing two kinases, IKK α and 
IKK β [36,37]. 
 
Once phosphorylated, IκB is ubiquitinated and 
subsequently degraded through 26S 
proteasome. Consequently, NFκB is freed to 
migrate into the nucleus, and binds to its 
consensus decameric sequence located in the 
promoter region of several genes involved in the 
pro-inflammatory response, encoding various 
immunoreceptors, cell adhesion molecules, 
cytokines and chemokines [34]. 
 
The first report in 2005 by Meng et al, 
demonstrated the effect of resveratrol on nuclear 
factor Kappa-B (NF-κB) and the inflammatory 
response in a rat model of severe acute 
pancreatitis. The rats treated with resveratrol 
were reported to have significantly lower levels of 
NF-κB, Tumour Necrosis Factor-α (TNF-α), and 
Interleukin-8 (IL-8) expressions compared to 
control animals. Moreover, histological 
examination of the pancreas showed less 
hyperaemia, necrosis, and oedema in the treated 
group [38].  
 
Role of activator protein-1 (AP-1) in the 
pathogenesis of acute pancreatitis 
 
AP-1 expression is induced by multiple stimuli 
such as inflammatory cytokines, mitogenic 
growth factors, phorbol esters, oncogenes and 
cellular stress among others. It is activated 
during the cell cycle to promote cell survival, 
differentiation and adaptive responses.  
 
NF-κB and AP-1 regulate many gene 
expressions which participate in immune and 
inflammatory responses. NF-κB is found in an 
inactive form in the cell cytoplasm attached to 
inhibitor protein kappa B (IκB). When activated, 
IκB is phosphorylated by specific IKK kinases 
and rapidly degraded though proteasome-
dependent pathways. The other transcription 
factor, AP-1 is a homo- or heterodimer complex 
molecule formed from Jun, Fos or the activating 
transcription factor subunits [3]. AP-1 is also 
involved in tissue proliferation, differentiation and 
transformation as observed in adult tissues and 
plays a key role in the regulation of the 
inflammatory process. AP-1 can be activated by 
growth factors, cytokines, chemokines, 
hormones and multiple environmental factors [3]. 
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Mitogen-activated protein kinases (MAPKs) 
 
MAPKs are a family of serine/threonine kinases 
activated by a cascade of intracellular 
phosphorylation events and transduce signals 
from the cell surface to the nucleus [39,40]. 
There are three well-characterized sub-families 
of MAPKs that control an array of physiological 
processes. It is generally believed that ERKs 
function in the control of cell division and Jun- N 
terminal kinases (JNKs) are critical regulators of 
transcription and p38 MAPKs are activated by 





The current review describes the various 
inflammatory mediators that influence the 
pathogenesis of acute pancreatitis. Acinar cell 
injury by trypsinogen activation plays a critical 
role in the pathogenesis mechanism of acute 
pancreatitis. The severity of cell death depends 
on the level of both pro-inflammatory and 
inflammatory mediators which involve the 
development of both apoptosis and necrotic 
pancreatic cell death. It is hoped that this review 
will assist investigators to better understand the 
mechanisms involved in the pathogenesis of 
acute pancreatitis and thus facilitate the 
development of more effective therapeutic 
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